Radiotherapy Market

Executive Summary

Radiotherapy Market was valued at US $10.29 billion in 2021 and is projected to grow at 6.08% CAGR over the forecast period to reach US $14.66 billion by 2027. Radiotherapy Market represented US $1.15 billion opportunity over 2019-2021 and estimated to create US $4.37 billion opportunity in 2027 over 2021.

Radiotherapy from Consainsights analyses the Radiotherapy Market in the Life Sciences industry over the forecast period to 2027.

Radiotherapy research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Radiotherapy segmentation includes Product Type, Type, Application, End User, Region and Geography.

Based on the Product Type, the Radiotherapy analysis covers External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy.

In Product Type segment, External Beam Radiotherapy segment has highest cagr growth of 5.38%.

Based on the Type, the Radiotherapy analysis covers External Beam Radiotherapy, Internal Beam Radiotherapy, Systemic Radiotherapy.

In Type segment, External Beam Radiotherapy segment has highest cagr growth of 5.38%.

Based on the Application, the Radiotherapy analysis covers External Beam Radiation Therapy, Internal Beam Radiotherapy/Brachytherapy.

In Application segment, External Beam Radiation Therapy segment has highest cagr growth of 5.38%.

Based on the End User, the Radiotherapy analysis covers Hospitals, Independent Radiotherapy Centers.

In End User segment, Hospitals segment has highest cagr growth of 5.38%.

Based on the Region, the Radiotherapy analysis covers North America, Europe, Asia Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 5.38%.

Based on the region, the Radiotherapy analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Accuray Incorporated, C. R. Bard, Inc., Elekta, Hitachi, Ltd., IBA (Ion Beam Applications Sa), Isoray Medical, Inc., Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healthcare, LLC., Sumitomo Heavy Industries, Ltd, Theragenics Corporation, Varian Medical Systems, Inc., Viewray Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product Type

Introduction

In 2021, External Beam Radiotherapy segment has the highest revenue of US $5.96 billion and is expected to grow at CAGR of 5.38% by 2027 External Beam Radiotherapy segment has highest cagr growth of 5.38%.

External Beam Radiotherapy

External Beam Radiotherapy segment was valued at US $5.29 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $8.48 billion by 2027. External Beam Radiotherapy segment represented US $0.66 billion opportunity over 2019-2021 and estimated to create US $2.53 billion opportunity in 2027 over 2021.

Internal Beam Radiotherapy/Brachytherapy

Internal Beam Radiotherapy/Brachytherapy segment was valued at US $2.71 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $4.34 billion by 2027. Internal Beam Radiotherapy/Brachytherapy segment represented US $0.34 billion opportunity over 2019-2021 and estimated to create US $1.29 billion opportunity in 2027 over 2021.

Systemic Radiotherapy

Systemic Radiotherapy segment was valued at US $1.14 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $1.83 billion by 2027. Systemic Radiotherapy segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.55 billion opportunity in 2027 over 2021.

Type

Introduction

In 2021, External Beam Radiotherapy segment has the highest revenue of US $4.72 billion and is expected to grow at CAGR of 5.38% by 2027 External Beam Radiotherapy segment has highest cagr growth of 5.38%.

External Beam Radiotherapy

External Beam Radiotherapy segment was valued at US $4.19 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $6.72 billion by 2027. External Beam Radiotherapy segment represented US $0.53 billion opportunity over 2019-2021 and estimated to create US $2.00 billion opportunity in 2027 over 2021.

Internal Beam Radiotherapy

Internal Beam Radiotherapy segment was valued at US $3.87 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $6.21 billion by 2027. Internal Beam Radiotherapy segment represented US $0.48 billion opportunity over 2019-2021 and estimated to create US $1.85 billion opportunity in 2027 over 2021.

Systemic Radiotherapy

Systemic Radiotherapy segment was valued at US $1.08 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $1.73 billion by 2027. Systemic Radiotherapy segment represented US $0.14 billion opportunity over 2019-2021 and estimated to create US $0.52 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Internal Beam Radiotherapy/Brachytherapy segment has the highest revenue of US $5.23 billion and is expected to grow at CAGR of 5.38% by 2027 External Beam Radiation Therapy segment has highest cagr growth of 5.38%.

External Beam Radiation Therapy

External Beam Radiation Therapy segment was valued at US $4.49 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $7.20 billion by 2027. External Beam Radiation Therapy segment represented US $0.56 billion opportunity over 2019-2021 and estimated to create US $2.15 billion opportunity in 2027 over 2021.

Internal Beam Radiotherapy/Brachytherapy

Internal Beam Radiotherapy/Brachytherapy segment was valued at US $4.65 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $7.46 billion by 2027. Internal Beam Radiotherapy/Brachytherapy segment represented US $0.58 billion opportunity over 2019-2021 and estimated to create US $2.22 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Independent Radiotherapy Centers segment has the highest revenue of US $5.41 billion and is expected to grow at CAGR of 5.38% by 2027 Hospitals segment has highest cagr growth of 5.38%.

Hospitals

Hospitals segment was valued at US $4.34 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $6.96 billion by 2027. Hospitals segment represented US $0.54 billion opportunity over 2019-2021 and estimated to create US $2.07 billion opportunity in 2027 over 2021.

Independent Radiotherapy Centers

Independent Radiotherapy Centers segment was valued at US $4.81 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $7.70 billion by 2027. Independent Radiotherapy Centers segment represented US $0.60 billion opportunity over 2019-2021 and estimated to create US $2.30 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $4.50 billion and is expected to grow at CAGR of 5.38% by 2027 North America segment has highest cagr growth of 5.38%.

North America

North America segment was valued at US $4.00 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $6.42 billion by 2027. North America segment represented US $0.50 billion opportunity over 2019-2021 and estimated to create US $1.91 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $2.36 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $3.78 billion by 2027. Europe segment represented US $0.30 billion opportunity over 2019-2021 and estimated to create US $1.13 billion opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $2.52 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $4.03 billion by 2027. Asia Pacific segment represented US $0.32 billion opportunity over 2019-2021 and estimated to create US $1.20 billion opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $0.27 billion in 2019 and is projected to grow at 5.38% CAGR over the forecast period to reach US $0.43 billion by 2027. Rest of the World segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.13 billion opportunity in 2027 over 2021.